论文部分内容阅读
肺纤维化是多种不同的肺间质疾病的共同结局。主要表现为进行性呼吸困难 ,干咳等症状 ,其死亡率较高。目前对其治疗以口服糖皮质激素为主。温润养血颗粒是根据曹世宏教授的临床经验方化裁而成。在临床应用中取得一定疗效。本实验采用博莱霉素引发的肺纤维化大鼠模型为实验对象
Pulmonary fibrosis is the common outcome of many different pulmonary interstitial diseases. Mainly manifested as progressive dyspnea, dry cough and other symptoms, the mortality rate is high. At present, it is mainly oral glucocorticoids. Wenrunyangxue granules are manufactured according to the clinical experience of Professor Cao Shihong. Obtain a certain effect in clinical application. In this study, a rat model of pulmonary fibrosis induced by bleomycin was used as a test subject.